ArticleNeuro-oncology2014
Are we done with dose-intense temozolomide in recurrent glioblastoma?
Article in Neuro-oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients.Medicine · 2017Trial
- High-Grade Thalamic Glioma: Case Report with Literature Review.Medicina (Kaunas, Lithuania) · 2024Review
- Retrospective study of nivolumab for patients with recurrent high grade gliomas.Journal of neuro-oncology · 2018Article
- Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.Journal of neuro-oncology · 2017Article
- Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences.Current treatment options in oncology · 2016Review
- Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma.Journal of Korean Neurosurgical Society · 2015Article
- Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.Oncotarget · 2015Article
- Molecularly targeted therapies for recurrent glioblastoma: current and future targets.Neurosurgical focus · 2014Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.